Roussakis, E. (2023). Pharmaceutical Data Exclusivity in the Light of Access to Clinical Data: Is the EMA oversharing?. Stockholm Intellectual Property Law Review , 6(2), 25 – 34. https://doi.org/10.53292/62cdf208.5b66823e